Novel uses of non-peptide bombesin receptor antagonists for treating anxiety and panic disorders
CA 2432066 A1 · Owner: Warner-Lambert Company · Inventors: Pritchard, Martyn Clive; Pinnock, Robert Denham
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
New uses have been found for compounds of formula (I) in which Ar Ar~1, R~1, R~2, R~3, R~4, R~5, R~6, R~7 R~8, R~9, j, k, l, m and n are as defined in the description. These uses for the diagnosis prevention, or treatment of , anxiety, social phobia and panic disorders pulmonary hypertension, lung , repair and lung development disorders prostate cancer, pancreatic cancer, hepatic porphyria visceral pain, gastrointestinal secretory disturbances including duodenal ulcer and <i>Helicobacter pylori</i> infection and neuropathic pain. There is also disclosed a method for diagnosing or treating cancers using a radiolabelled compound of Formula (I) and also a method for , treating cancers …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 20, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 20, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 20, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.